MX2010002734A - Derivados de 1-amino-alquilciclohexano para el tratamiento y prevencion de perdida auditiva. - Google Patents

Derivados de 1-amino-alquilciclohexano para el tratamiento y prevencion de perdida auditiva.

Info

Publication number
MX2010002734A
MX2010002734A MX2010002734A MX2010002734A MX2010002734A MX 2010002734 A MX2010002734 A MX 2010002734A MX 2010002734 A MX2010002734 A MX 2010002734A MX 2010002734 A MX2010002734 A MX 2010002734A MX 2010002734 A MX2010002734 A MX 2010002734A
Authority
MX
Mexico
Prior art keywords
amino
treatment
hearing loss
prevention
alkylcyclohexane derivatives
Prior art date
Application number
MX2010002734A
Other languages
English (en)
Inventor
Hagen Krueger
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of MX2010002734A publication Critical patent/MX2010002734A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Percussion Or Vibration Massage (AREA)

Abstract

La presente invenci?n se refiere al tratamiento de un individuo diagnosticado con p?rdida auditiva, que comprende administrar al individuo una cantidad efectiva de un derivado de 1-amino-alquilciclohexano.
MX2010002734A 2007-09-12 2008-09-10 Derivados de 1-amino-alquilciclohexano para el tratamiento y prevencion de perdida auditiva. MX2010002734A (es)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US99339607P 2007-09-12 2007-09-12
EP07253630 2007-09-12
US6702608P 2008-02-25 2008-02-25
US6693108P 2008-02-25 2008-02-25
US6708308P 2008-02-25 2008-02-25
EP08004776 2008-03-14
EP08004777 2008-03-14
EP08004778 2008-03-14
PCT/EP2008/007419 WO2009033650A1 (en) 2007-09-12 2008-09-10 1-amino-alkylcyclohexane derivatives for the treatment and prevention of hearing loss

Publications (1)

Publication Number Publication Date
MX2010002734A true MX2010002734A (es) 2010-04-01

Family

ID=40451596

Family Applications (4)

Application Number Title Priority Date Filing Date
MX2010002733A MX2010002733A (es) 2007-09-12 2008-09-10 Terapia de intervalo para el tratamiento de tinnitus.
MX2010002736A MX2010002736A (es) 2007-09-12 2008-09-10 Derivados de 1-amino-alquilciclohexano para el tratamiento de tinnitus coclear.
MX2010002735A MX2010002735A (es) 2007-09-12 2008-09-10 Envase de titulacion para neramexano y su uso en el tratamiento de un trastorno del oido interno.
MX2010002734A MX2010002734A (es) 2007-09-12 2008-09-10 Derivados de 1-amino-alquilciclohexano para el tratamiento y prevencion de perdida auditiva.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
MX2010002733A MX2010002733A (es) 2007-09-12 2008-09-10 Terapia de intervalo para el tratamiento de tinnitus.
MX2010002736A MX2010002736A (es) 2007-09-12 2008-09-10 Derivados de 1-amino-alquilciclohexano para el tratamiento de tinnitus coclear.
MX2010002735A MX2010002735A (es) 2007-09-12 2008-09-10 Envase de titulacion para neramexano y su uso en el tratamiento de un trastorno del oido interno.

Country Status (21)

Country Link
US (6) US9468610B2 (es)
EP (6) EP2548552B1 (es)
JP (6) JP5563460B2 (es)
KR (4) KR20100052557A (es)
CN (4) CN101801366A (es)
AR (3) AR071728A1 (es)
AT (1) ATE532507T1 (es)
AU (4) AU2008298016B2 (es)
BR (2) BRPI0816712A2 (es)
CA (4) CA2699213A1 (es)
DK (1) DK2200600T3 (es)
ES (5) ES2596262T3 (es)
HR (1) HRP20120046T1 (es)
MX (4) MX2010002733A (es)
PL (1) PL2200600T3 (es)
PT (1) PT2200600E (es)
RU (1) RU2011137131A (es)
SI (1) SI2200600T1 (es)
TW (3) TW200927087A (es)
WO (4) WO2009033652A1 (es)
ZA (4) ZA201001261B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2596262T3 (es) * 2007-09-12 2017-01-05 Merz Pharma Gmbh & Co. Kgaa Derivados de 1-amino-alquilciclohexano para su uso en el tratamiento de tinnitus asociado con pérdida de audición
US20110294890A1 (en) 2010-05-28 2011-12-01 Merz Pharma Gmbh & Co. Kgaa Neramexane for the treatment or prevention of inner ear disorders
JP2013529604A (ja) * 2010-06-24 2013-07-22 メルツ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト アウフ アクティーン ネラメキサン複数単位剤形
WO2012098000A1 (en) 2011-01-20 2012-07-26 Merz Pharma Gmbh & Co. Kgaa Neramexane for the treatment or prevention of tinnitus related with stress or acute hearing loss
JP6542678B2 (ja) * 2013-03-06 2019-07-10 アコーダ セラピューティクス インコーポレイテッド 心不全の治療または予防のためのニューレグリンまたはその断片の治療的投与の方法
EA201692164A1 (ru) * 2014-04-28 2017-03-31 Керин Фармасьютикал Ко., Лтд. Лекарственное средство для лечения пациентов с тиннитусом
EA201692163A1 (ru) * 2014-04-28 2017-03-31 Керин Фармасьютикал Ко., Лтд. Лекарственное средство для лечения пациентов с тиннитусом
JP6768646B2 (ja) * 2014-10-23 2020-10-14 アリーナ ファーマシューティカルズ， インコーポレイテッド Ｐｇｉ２受容体に関連した状態の治療法
WO2016184900A1 (en) * 2015-05-18 2016-11-24 Sensorion Calcineurin inhibitors of the setron family for the treatment of hearing loss
KR101893604B1 (ko) 2015-08-27 2018-08-30 경희대학교 산학협력단 칸디다 유틸리스 추출물을 포함하는 난청의 예방 또는 치료용 조성물
CN105924362B (zh) * 2016-02-05 2018-08-17 上海龙翔生物医药开发有限公司 芳香环丙基胺类化合物、其药学上可接受的盐、其制备方法及其用途
ES2965069T3 (es) 2017-03-01 2024-04-11 Arena Pharm Inc Composiciones que comprenden agonistas del receptor de PGI2 y procesos para la preparación de las mismas
KR102268893B1 (ko) 2020-01-16 2021-06-24 경북대학교 산학협력단 림노트릭스 속 knua002 균주를 포함하는 난청의 예방 또는 치료용 조성물
CN111477199B (zh) * 2020-04-02 2021-11-30 北京瑞迪欧文化传播有限责任公司 一种嵌入式音乐控制系统

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024983A (en) 1986-10-24 2000-02-15 Southern Research Institute Composition for delivering bioactive agents for immune response and its preparation
US4849222A (en) 1987-03-24 1989-07-18 The Procter & Gamble Company Mixtures for treating hypercholesterolemia
JP2670680B2 (ja) 1988-02-24 1997-10-29 株式会社ビーエムジー 生理活性物質含有ポリ乳酸系微小球およびその製造法
US5288502A (en) 1991-10-16 1994-02-22 The University Of Texas System Preparation and uses of multi-phase microspheres
JPH09504027A (ja) 1993-10-22 1997-04-22 ジェネンテク，インコーポレイテッド ワクチンとしての使用のための抗原のマイクロカプセル化のための方法および組成物
DE19528388A1 (de) * 1995-08-02 1997-02-06 Hans Peter Prof Dr Med Zenner Verwendung von Adamantan-Derivaten zur Behandlung von Erkrankungen des Innenohrs
AU4424697A (en) 1996-09-11 1998-04-02 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The The use of functional n-methyl-d-aspartate antagonists to ameliorate or prevent aminoglycoside-induced ototoxicity
CZ293248B6 (cs) 1997-06-30 2004-03-17 Merz Pharma Gmbh & Co. Kgaa 1-Aminocyklohexanový derivát a farmaceutická kompozice na jeho bázi
US6071966A (en) 1997-06-30 2000-06-06 Merz + Co. Gmbh & Co. 1-amino-alkylcyclohexane NMDA receptor antagonists
EP1278716B1 (en) * 2000-04-26 2006-08-23 Warner-Lambert Company LLC Trans-n-¬4-(4-hydroxyphenyl)cyclohexyl|-3-phenylpropionamide as subtype selective nmda receptor antagonist
DE10048969A1 (de) * 2000-08-23 2002-03-14 Mueller Schwefe Gerhard Verwendung von Flupirtin zur Tinnitusbehandlung
US20030236288A1 (en) * 2002-02-28 2003-12-25 Karl Schoenafinger Use of substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadizol-2-ones for inhibiting pancreatic lipase
JP2004021734A (ja) 2002-06-18 2004-01-22 Nokia Corp キーパッドおよびキーパッドシステム
US7086532B2 (en) * 2003-07-16 2006-08-08 Allergan, Inc. Titration/compliance pack with increasing doses
EP1545551A4 (en) * 2002-09-06 2008-10-22 Durect Corp DISTRIBUTION OF MODULATORS OF THE GLUTAMAT-MEDIATED NEUROTRANSMISSION TO THE INNER EAR
DE10252665A1 (de) 2002-11-11 2004-06-03 Grünenthal GmbH 4-Aminomethyl-1-aryl-cyclohexylamin-Derivate
RS20050851A (sr) 2003-05-27 2008-04-04 Forest Laboratories Inc., Kombinacija antagonista nmda receptora i selektivnog inhibitora ponovnog preuzimanja serotonina za lečenje depresije i drugih poremećaja raspoloženja
AR046314A1 (es) * 2003-11-05 2005-11-30 Merz Pharma Gmbh & Co Kgaa Composiciones que comprenden ciclohexilaminas y aminoadamantanos
CN101389315A (zh) * 2004-06-17 2009-03-18 莫茨药物股份两合公司 美金刚口服剂型即释制剂
US20060002999A1 (en) 2004-06-17 2006-01-05 Forest Laboratories, Inc. Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
US20060205822A1 (en) 2004-12-22 2006-09-14 Forest Laboratories, Inc. 1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
EP1861161A4 (en) * 2005-01-24 2012-05-16 Neurosystec Corp APPARATUS AND METHOD FOR DISPENSING THERAPEUTIC AND / OR OTHER AGENTS IN THE INTERNAL EAR AND OTHER FABRICS
JP2008531726A (ja) * 2005-03-04 2008-08-14 ニューロシステック コーポレイション 改良されたガシクリジン製剤
TWI265036B (en) * 2005-04-29 2006-11-01 Guo-Ming Huang Safety injector and method of operating the same
WO2006124838A1 (en) * 2005-05-18 2006-11-23 Gt Urological, Llc. Drug elution for implantable incontinence devices
CN1896729A (zh) 2005-07-15 2007-01-17 复旦大学附属中山医院 纳米药物自组装双稳态量子线阵列及其制备方法
US20070141148A1 (en) * 2005-11-30 2007-06-21 Merz Pharma Gmbh & Co. Kgaa Neramexane MR matrix tablet
TW200819458A (en) * 2006-06-23 2008-05-01 Merz Pharma Gmbh & Co Kgaa Metabotropic glutamate receptor modulators
ES2596262T3 (es) * 2007-09-12 2017-01-05 Merz Pharma Gmbh & Co. Kgaa Derivados de 1-amino-alquilciclohexano para su uso en el tratamiento de tinnitus asociado con pérdida de audición
TW201010691A (en) * 2008-06-12 2010-03-16 Merz Pharma Gmbh & Co Kgaa 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
TW201006463A (en) * 2008-06-26 2010-02-16 Merz Pharma Gmbh & Co Kgaa Pharmaceutical compositions comprising aminocyclohexane derivatives
CN102123703A (zh) * 2008-09-10 2011-07-13 莫茨药物股份两合公司 用于治疗耳鸣中认知损害的1-氨基-烷基环己烷衍生物
US20110294890A1 (en) * 2010-05-28 2011-12-01 Merz Pharma Gmbh & Co. Kgaa Neramexane for the treatment or prevention of inner ear disorders
WO2012098000A1 (en) * 2011-01-20 2012-07-26 Merz Pharma Gmbh & Co. Kgaa Neramexane for the treatment or prevention of tinnitus related with stress or acute hearing loss

Also Published As

Publication number Publication date
AU2008298018B2 (en) 2012-01-19
MX2010002733A (es) 2010-04-09
JP5563461B2 (ja) 2014-07-30
EP2200600B1 (en) 2011-11-09
DK2200600T3 (da) 2012-01-23
CA2699209A1 (en) 2009-03-19
MX2010002736A (es) 2010-04-01
CN101801366A (zh) 2010-08-11
AR070026A1 (es) 2010-03-10
EP2386299B1 (en) 2016-07-13
EP2548552B1 (en) 2015-11-18
US20100298440A1 (en) 2010-11-25
ES2377253T3 (es) 2012-03-23
US20100298441A1 (en) 2010-11-25
US9498450B2 (en) 2016-11-22
CA2699207A1 (en) 2009-03-19
AU2008298015B2 (en) 2012-03-22
EP2200600A1 (en) 2010-06-30
ZA201001263B (en) 2011-07-27
ES2604945T3 (es) 2017-03-10
JP2014221767A (ja) 2014-11-27
KR20100052557A (ko) 2010-05-19
KR20100052556A (ko) 2010-05-19
PT2200600E (pt) 2012-02-17
ZA201001262B (en) 2011-07-27
WO2009033651A1 (en) 2009-03-19
CA2699213A1 (en) 2009-03-19
BRPI0816712A2 (pt) 2016-11-08
PL2200600T3 (pl) 2012-04-30
ES2596262T3 (es) 2017-01-05
AU2008298018C1 (en) 2012-08-16
EP2386299A2 (en) 2011-11-16
US20150018425A1 (en) 2015-01-15
EP2200599A1 (en) 2010-06-30
EP2203163A1 (en) 2010-07-07
JP2010539117A (ja) 2010-12-16
US8877814B2 (en) 2014-11-04
US20110086916A1 (en) 2011-04-14
US9468610B2 (en) 2016-10-18
JP2010539118A (ja) 2010-12-16
BRPI0816690A2 (pt) 2016-11-01
JP5563460B2 (ja) 2014-07-30
TW200922544A (en) 2009-06-01
JP2010539115A (ja) 2010-12-16
WO2009033652A1 (en) 2009-03-19
ATE532507T1 (de) 2011-11-15
AR071728A1 (es) 2010-07-14
TW200927087A (en) 2009-07-01
KR20100052559A (ko) 2010-05-19
CA2699210A1 (en) 2009-03-19
EP2200598A1 (en) 2010-06-30
CN101795679A (zh) 2010-08-04
ZA201001264B (en) 2011-07-27
AR070025A1 (es) 2010-03-10
JP2014221766A (ja) 2014-11-27
HRP20120046T1 (hr) 2012-02-29
KR20100052558A (ko) 2010-05-19
CN101801365A (zh) 2010-08-11
MX2010002735A (es) 2010-04-01
TW200918042A (en) 2009-05-01
JP2010539116A (ja) 2010-12-16
AU2008298018A1 (en) 2009-03-19
JP5613053B2 (ja) 2014-10-22
JP5612473B2 (ja) 2014-10-22
ES2562709T3 (es) 2016-03-07
CN101835469A (zh) 2010-09-15
AU2008298015A1 (en) 2009-03-19
JP5784188B2 (ja) 2015-09-24
WO2009033649A1 (en) 2009-03-19
US20110077304A1 (en) 2011-03-31
JP5784189B2 (ja) 2015-09-24
ZA201001261B (en) 2011-08-31
AU2008298017A1 (en) 2009-03-19
US20170027885A1 (en) 2017-02-02
AU2008298017B2 (en) 2012-03-01
WO2009033650A1 (en) 2009-03-19
EP2548552A2 (en) 2013-01-23
AU2008298016A1 (en) 2009-03-19
ES2510565T3 (es) 2014-10-21
EP2203163B1 (en) 2014-08-27
EP2386299A3 (en) 2012-05-02
SI2200600T1 (sl) 2012-03-30
RU2011137131A (ru) 2013-03-20
EP2200599B1 (en) 2016-08-31
EP2548552A3 (en) 2013-10-16
AU2008298016B2 (en) 2012-02-02

Similar Documents

Publication Publication Date Title
MX2010002734A (es) Derivados de 1-amino-alquilciclohexano para el tratamiento y prevencion de perdida auditiva.
WO2009089494A3 (en) Pharmaceutical compositions
MX2010006823A (es) Metodos para el tratamiento de la gota.
MX2011007930A (es) Conjugados de insulina cristalina.
MX343822B (es) Inhibidores selectivos de glucosidasas, y usos de los mismos.
IN2012DN00624A (es)
IN2012DN02469A (es)
TN2010000122A1 (en) Compounds and compositions as modulators of gpr119 activity
PL2134704T3 (pl) Związki i kompozycje pełniące rolę modulatorów aktywności GPR119
MY150602A (en) Subtituted-quinoxaline-type piperidine compounds and the uses thereof
MX2010001300A (es) Uso de hesperidina o un derivado de la misma para prevencion y/o tratamiento de pieles flacidas.
WO2008070268A3 (en) Pharmaceutical compositions
UA96592C2 (uk) Індолопіридини як модулятори кінезину eg5
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
MX2012004078A (es) Compuestos y composiciones como moduladores de la actividad de gpr119.
UA107666C2 (uk) Застосування l-серину як лікарського засобу для попередження та/або лікування свербіжу шкіри
MX2009005725A (es) Metodos y composiciones para tratamiento y monitoreo de tratamiento de trastornos asociados con il-13.
MX2009009190A (es) Compuestos heterociclicos, composiciones que los comprenden y metodos que los emplean.
JO3676B1 (ar) مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها
IN2012DN03404A (es)
IL196839A0 (en) Antioxidant for preventing and treating diseases caused by oxidative stress
WO2011011706A3 (en) Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents
IL198202A0 (en) Peptide-cytotoxic conjugates
AU327040S (en) Filter
MX2009012761A (es) Neramexano para el tratamiento de nistagmo.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal